Cautious optimism defined this year's JP Morgan Healthcare Conference, fueled by a flurry of Merger Monday deals, anticipated Fed rate cuts, and growing big pharma appetite for smaller biotech companies. We break down the key 2024 takeaways: an improving M&A landscape favoring 'large acquiring small,' a shift away from COVID-19 products toward novel mechanisms of action like ADCs and CAR-Ts, and AI's accelerating, bidirectional role in reshaping healthcare innovation and inve

Our Gene Therapy HTIA includes market insights and dynamics, detailed sector and sub-sector descriptions, and companies differentiated by se

In early 2020, the first AI-designed drug entered human clinical trials. Less than three years later, the FDA granted its first Orphan Drug